Daniel J. Abdun-Nabi

Daniel J. Abdun-Nabi

Daniel J. Abdun-Nabi

President & CEO, Emergent BioSolutions

Mr. Abdun-Nabi is the President and Chief Executive Officer of Emergent BioSolutions Inc., a NYSE-listed global life sciences company dedicated to protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats.

In 2016, Mr. Abdun-Nabi was appointed by Maryland Governor Larry Hogan as Chairman of the Maryland Life Sciences Advisory Board, which was established to accelerate the growth of Maryland’s biohealth and technology ecosystem.  He also serves as a member of the board of directors and board of advisors for a number of non-profit, economic development, educational, and other organizations including as: Vice Chairman of BioHealth Innovation; Member of the Board of Advisors, Universities at Shady Grove, part of the University System of Maryland; and Member of the Advisory Board for FM Global, a worldwide commercial and industrial property insurance company.  Additionally, he is a member of the Board of Directors of Emergent BioSolutions, Aptevo Therapeutics, a publicly-traded biotechnology company focused on novel oncology and hematology therapeutics, and REGENXBIO, a publicly-traded biotechnology company focused on in-vivo gene therapy products.

Mr. Abdun-Nabi has also served as a member of the Board of Directors for the National Association of Manufacturers, as Co-Chair for the Montgomery County Community Advisory Group, as Chairman of the Board for the Oxford Emergent Tuberculosis Consortium (a UK joint venture established with Oxford University to develop a novel TB vaccine) and as Chairman of the Board of EPIC BIO (a Singapore joint venture established to develop a novel pandemic flu vaccine).